R. Zand et al., INHIBITION AND INDUCTION OF CYTOCHROME P4502E1-CATALYZED OXIDATION BYISONIAZID IN HUMANS, Clinical pharmacology and therapeutics, 54(2), 1993, pp. 142-149
We studied the effect of isoniazid administration on the cytochrome P4
502E1-catalyzed elimination of chlorzoxazone and acetaminophen. Isonia
zid, 300 mg daily, was administered for 7 days to a group of 10 volunt
eer slow acetylators. Acetaminophen, 500 mg, and chlorzoxazone, 750 mg
, were administered on separate occasions before isoniazid, during the
period of isoniazid administration, and after the discontinuation of
isoniazid. Isoniazid inhibited the clearance of chlorzoxazone by 58%,
as assessed from plasma data, and inhibited the formation of acetamino
phen thioether metabolites (a measure of the formation of the hepatoto
xin N-acetyl-p-benzoquinone imine and catechol oxidative metabolites o
f acetaminophen, as determined from their recovery in urine, by 63% an
d 49%, respectively. Two days after the discontinuation of isoniazid,
the clearance of chlorzoxazone was increased over the value before iso
niazid by 56%. Acetaminophen thioether but not catechol metabolites we
re increased by 56% 1 day after the discontinuation of isoniazid and h
ad returned to the pre-isoniazid value 3 days after the discontinuatio
n of isoniazid. We conclude that the time course of the interaction wi
th regard to chlorzoxazone elimination and formation is compatible wit
h an inhibition-induction effect of isoniazid on cytochrome P4502E1. T
he mechanism of this biphasic effect is probably induction by protein
stabilization, which results in inhibition of catalytic activity while
isoniazid is present.